Christine Marie Utter, SVP, CHIEF ACCOUNTING OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 34,992 shares at $52.45 ($1.8M) on 2024-12-02, disclosed to the SEC on 2024-12-04.
Scheduled sale ($1.8M) by SVP, CHIEF ACCOUNTING OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.34 | 2,497 | $128K | 7.1% |
| 2 | $51.34 | 2,497 | $128K | 7.1% |
| 3 | $51.53 | 9,919 | $511K | 28.2% |
| 4 | $51.53 | 9,919 | $511K | 28.2% |
| 5 | $52.24 | 608 | $32K | 1.8% |
| 6 | $52.45 | 4,776 |
| $251K |
| 13.8% |
| 7 | $52.45 | 4,776 | $251K | 13.8% |
| Total | $51.77 avg | 34,992 | $1.8M | 100% |
| Filing → |
| PTCT | SELL | 2026-01-12 | $79K | — | Filing → |
| PTCT | SELL | 2026-01-08 | $202K | — | Filing → |
| PTCT | SELL | 2025-02-21 | $88K | — | Filing → |